CD 10899
Product Specifications
CAS Number
1331770-20-7
Target
PLK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CD 10899, a hydroxylated metabolite of Volasertib, is pharmacologically active against Polo-like kinase 1 (PLK1) with an IC50 of 6 nM. Volasertib is an orally active, highly potent, and ATP-competitive PLK1 inhibitor. CD 10899 can be used for cancer research [1].
Smiles
C(C)(C)N1C=2C(N(C)C(=O)C1(CC)O)=CN=C(NC3=C(OC)C=C(C(N[C@H]4CC[C@@H](CC4)N5CCN(CC6CC6)CC5)=O)C=C3)N2
Molecular Formula
C34H50N8O4
Molecular Weight
634.81
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15359450 1 Vial
Lentiviral human ISG15 sgRNA gene knockout kit - Lentiviral human ISG15 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 
125769-APC 100 µL
DENR (Density-regulated Protein, DRP, Protein DRP1, Smooth Muscle Cell-associated Protein 3, SMAP-3, DRP1, H14) (APC)
Sign In for Pricing
View Details MBS7088430-01 0.05 mg (E-Coli)
Recombinant Macrovipera lebetina Lebetin-2-alpha
Sign In for Pricing
View Details MBS7088430-02 0.2 mg (E-Coli)
Recombinant Macrovipera lebetina Lebetin-2-alpha
Sign In for Pricing
View Details